Geneev Christeena, Mathew Nisha, Jacob Jubbin Jagan
Christian Medical College and Hospital, Ludhiana, Punjab, India.
Department of Medicine, Endocrine and Diabetes Unit, Christian Medical College and Hospital, Ludhiana, Punjab, India.
Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):280-282. doi: 10.4103/ijem.IJEM_29_18.
Patients with diabetes mellitus are more prone to develop infections with influenza virus and pneumococcus. Once they develop respiratory infections, they are twice more likely to die of complication related to the infection. Although there are no Indian guidelines, recent publications have recommended vaccination in patients with diabetes of all ages. Our study was undertaken to find the barriers to the uptake of adult vaccination against respiratory illness among patients with diabetes attending a diabetic clinic in a tertiary care institution. Of the 149 patients interviewed, only 2% and 0.7% had been previously vaccinated against influenza and pneumococcus, respectively. Although 52% of patients agreed that vaccination was safe and effective, only 17.4% got vaccinated during the period of observation after counseling. The primary reasons for refusal were financial (51.7%), while some were not completely convinced of its benefits (9.4%); the other reasons included fear of complications (7.4%) and needles (0.7%).
糖尿病患者更容易感染流感病毒和肺炎球菌。一旦他们发生呼吸道感染，死于感染相关并发症的可能性会高出两倍。尽管没有印度的相关指南，但最近的出版物建议所有年龄段的糖尿病患者接种疫苗。我们开展这项研究是为了找出在一家三级医疗机构的糖尿病诊所就诊的糖尿病患者接受成人呼吸道疾病疫苗接种的障碍。在接受访谈的149名患者中，之前分别只有2%和0.7%的人接种过流感疫苗和肺炎球菌疫苗。尽管52%的患者认同接种疫苗是安全有效的，但在咨询后的观察期内只有17.4%的人接种了疫苗。拒绝接种的主要原因是费用问题（51.7%），而一些人并不完全相信其益处（9.4%）；其他原因包括担心并发症（7.4%）和害怕打针（0.7%）。
